Regulation of antiviral CD8+ T cells by inhibitory natural killer cell receptors

Microbes and Infection

Volumn 5, Issue 2, 2003, Pages 169-177

  Byers, Anthony M ^a   Kemball, Christopher C ^a   Andrews, Nicolas P ^a   Lukacher, Aron E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD8+ T lymphocyte; Killer cells, natural; T cell receptor; Viruses

Indexed keywords

CD8 ANTIGEN; RECEPTOR;

BYSTANDER EFFECT; CELL ASSAY; CELL LINE; INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0037297467     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00086-2     Document Type: Review

References (100)

1. Ljunggren H.G., Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today. 11:1990;237-244.
2. Lanier L.L. On guard - activating NK cell receptors. Nat. Immunol. 2:2001;23-27.
3. MacDonald H.R. Development and selection of NKT cells. Curr. Opin. Immunol. 14:2002;250-254.
4. + T cells expressing NK cell receptors in influenza A virus-infected mice. J. Immunol. 165:2000;4964-4969.
5. + T cells. J. Immunol. 164:2000;2009-2015.
6. + T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J. Immunol. 165:2000;3673-3679.
7. Coles M.C., McMahon C.W., Takizawa H., Raulet D.H., Memory C.D. T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur. J. Immunol. 30:2000;236-244.
8. + T cells upon NK T or T cell activation. J. Immunol. 165:2000;4305-4311.
9. + T cells. J. Immunol. 169:2002;1444-1452.
10. + T cells. J. Immunol. 169:2002;693-701.
11. + T cell responses. Nat. Immunol. 3:2002;189-195.
12. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:2002;251-262.
13. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:1999;708-712.
14. De Maria A., Ferraris A., Guastella M., Pilia S., Cantoni C., Polero L., Mingari M.C., Bassetti D., Fauci A.S., Moretta L. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl. Acad. Sci. USA. 94:1997;10285-10288.
15. Andre P., Brunet C., Guia S., Gallais H., Sampol J., Vivier E., Dignat-George F. Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals. Eur. J. Immunol. 29:1999;1076-1085.
16. Vely F., Peyrat M., Couedel C., Morcet J., Halary F., Davodeau F., Romagne F., Scotet E., Saulquin X., Houssaint E., Schleinitz N., Moretta A., Vivier E., Bonneville M. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol. 166:2001;2487-2494.
17. Zajac A.J., Vance R.E., Held W., Sourdive D.J., Altman J.D., Raulet D.H., Ahmed R. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J. Immunol. 163:1999;5526-5534.
18. Oberg L., Eriksson M., Fahlen L., Sentman C.L. Expression of Ly49A on T cells alters the threshold for T cell responses. Eur. J. Immunol. 30:2000;2849-2856.
19. Pauza M., Smith K.M., Neal H., Reilly C., Lanier L.L., Lo D. Transgenic expression of Ly-49A in thymocytes alters repertoire selection. J. Immunol. 164:2000;884-892.
20. Fahlen L., Oberg L., Brannstrom T., Khoo N.K., Lendahl U., Sentman C.L. Ly49A expression on T cells alters T cell selection. Int. Immunol. 12:2000;215-222.
21. + T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2. J. Virol. 74:2000;7032-7038.
22. Freund R., Sotnikov A., Bronson R.T., Benjamin T.L. Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology. 191:1992;716-723.
23. Lukacher A.E., Ma Y., Carroll J.P., Abromson-Leeman S.R., Laning J.C., Dorf M.E., Benjamin T.L. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. M. 181:1995;1683-1692.
24. Moser J.M., Altman J.D., Lukacher A.E., Antiviral C.D. T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J. Exp. M. 193:2001;595-606.
25. Speiser D.E., Pittet M.J., Valmori D., Dunbar R., Rimoldi D., Lienard D., MacDonald H.R., Cerottini J.C., Cerundolo V., Romero P. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. M. 190:1999;775-782.
26. Voehringer D., Blaser C., Brawand P., Raulet D.H., Hanke T., Pircher H. Viral infections induce abundant numbers of senescent CD8 T cells. J. Immunol. 167:2001;4838-4843.
27. Moser J.M., Byers A.M., Lukacher A.E. NK cell receptors in antiviral immunity. Curr. Opin. Immunol. 14:2002;509-516.
28. Valitutti S., Muller S., Dessing M., Lanzavecchia A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. M. 183:1996;1917-1921.
29. Hanke T., Raulet D.H. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. J. Immunol. 166:2001;3002-3007.
30. Roger J., Chalifour A., Lemieux S., Duplay P., Ly A., inhibits T.C.R. CD3-induced apoptosis and IL-2 secretion. J. Immunol. 167:2001;6-10.
31. + T cells. Nat. Immunol. 2:2001;430-435.
32. Bertone S., Schiavetti F., Bellomo R., Vitale C., Ponte M., Moretta L., Mingari M.C. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur. J. Immunol. 29:1999;23-29.
33. Derre L., Corvaisier M., Pandolfino M.C., Diez E., Jotereau F., Gervois N. Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy. J. Immunol. 168:2002;4864-4870.
34. Mingari M.C., Moretta A., Moretta L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol. Today. 19:1998;153-157.
35. + T cells. Proc. Natl. Acad. Sci. USA. 95:1998;1172-1177.
36. Galiani M.D., Aguado E., Tarazona R., Romero P., Molina I., Santamaria M., Solana R., Pena J. Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals. Clin. Exp. Immunol. 115:1999;472-476.
37. Quaranta M.G., Camponeschi B., Straface E., Malorni W., Viora M. Induction of interleukin-15 production by HIV-1 nef protein: a role in the proliferation of uninfected cells. Exp. Cell Res. 250:1999;112-121.
38. Tangsinmankong N., Day N.K., Good R.A., Haraguchi S. Monocytes are target cells for IL-10 induction by HIV-1 nef protein. Cytokine. 12:2000;1506-1511.
39. Rasty S., Thatikunta P., Gordon J., Khalili K., Amini S., Glorioso J.C. Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proc. Natl. Acad. Sci. USA. 93:1996;6073-6078.
40. Zauli G., Davis B.R., Re M.C., Visani G., Furlini G., La Placa M. Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood. 80:1992;3036-3043.
41. Azimi N., Tagaya Y., Mariner J., Waldmann T.A. Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region. J. Virol. 74:2000;7338-7348.
42. Azimi N., Brown K., Bamford R.N., Tagaya Y., Siebenlist U., Waldmann T.A. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc. Natl. Acad. Sci. USA. 95:1998;2452-2457.
43. Mattei F., Schiavoni G., Belardelli F., Tough D.F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167:2001;1179-1187.
44. Becker T.C., Wherry E.J., Boone D., Murali-Krishna K., Antia R., Ma A., Ahmed R. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. M. 195:2002;1541-1548.
45. Schluns K.S., Williams K., Ma A., Zheng X.X., Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168:2002;4827-4831.
46. + T cells. J. Immunol. 164:2000;3950-3954.
47. + T cells deficient in the IL-15 receptor alpha-chain. J. Immunol. 168:2002;705-712.
48. + T cells. J. Exp. M. 195:2002;1515-1522.
49. + T cells. J. Exp. M. 195:2002;1533-1539.
50. + cells. J. Exp. M. 195:2002;1523-1532.
51. 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology. 252:1998;275-284.
52. + T cells is controlled by T-cell receptor engagement. Nature. 403:2000;325-328.
53. Chun T., Aldrich C.J., Baldeon M.E., Kawczynski L.V., Soloski M.J., Gaskins H.R. Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells. Immunology. 94:1998;64-71.
54. Cerboni C., Mousavi-Jazi M., Wakiguchi H., Carbone E., Karre K., Soderstrom K. Synergistic effect of IFN-γ and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Eur. J. Immunol. 31:2001;2926-2935.
55. Vales-Gomez M., Reyburn H.T., Erskine R.A., Lopez-Botet M., Strominger J.L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18:1999;4250-4260.
56. Malmberg K.J., Levitsky V., Norell H., Teixeira de Matos C., Carlsten M., Schedvins K., Rabbani H., Moretta A., Soderstrom K., Levitskaya J., Kiessling R. IFN-γ protects short-term ovarian carcinoma cell lines from cytotoxic T lymphocyte lysis via a CD94/NKG2A dependent mechanism. J. Clin. Invest. 110:2002;1515-1523.
57. Fahlen L., Khoo N.K., Daws M.R., Sentman C.L. Location-specific regulation of transgenic Ly49A receptors by major histocompatibility complex class I molecules. Eur. J. Immunol. 27:1997;2057-2065.
58. Held W., Raulet D.H. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J. Exp. M. 185:1997;2079-2088.
59. b peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J. Exp. M. 192:2000;613-624.
60. Tomasec P., Braud V.M., Rickards C., Powell M.B., McSharry B.P., Gadola S., Cerundolo V., Borysiewicz L.K., McMichael A.J., Wilkinson G.W. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science. 287:2000;1031.
61. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 10:1999;661-671.
62. Llano M., Lee N., Navarro F., Garcia P., Albar J.P., Geraghty D.E., Lopez-Botet M. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28:1998;2854-2863.
63. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science. 290:2000;84-89.
64. Binstadt B.A., Brumbaugh K.M., Dick C.J., Scharenberg A.M., Williams B.L., Colonna M., Lanier L.L., Kinet J.P., Abraham R.T., Leibson P.J. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity. 5:1996;629-638.
65. Plas D.R., Johnson R., Pingel J.T., Matthews R.J., Dalton M., Roy G., Chan A.C., Thomas M.L. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science. 272:1996;1173-1176.
66. Le Drean E., Vely F., Olcese L., Cambiaggi A., Guia S., Krystal G., Gervois N., Moretta A., Jotereau F., Vivier E. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 28:1998;264-276.
67. Kosugi A., Sakakura J., Yasuda K., Ogata M., Hamaoka T. Involvement of SHP-1 tyrosine phosphatase in TCR-mediated signaling pathways in lipid rafts. Immunity. 14:2001;669-680.
68. Carretero M., Palmieri G., Llano M., Tullio V., Santoni A., Geraghty D.E., Lopez-Botet M. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur. J. Immunol. 28:1998;1280-1291.
69. Su M.W., Yu C.L., Burakoff S.J., Jin Y.J. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation. J. Immunol. 166:2001;3975-3982.
70. Lorenz U., Ravichandran K.S., Burakoff S.J., Neel B.G. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc. Natl. Acad. Sci. USA. 93:1996;9624-9629.
71. Marti F., Xu C.W., Selvakumar A., Brent R., Dupont B., King P.D. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA. 95:1998;11810-11815.
72. Bromley S.K., Burack W.R., Johnson K.G., Somersalo K., Sims T.N., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse. Annu. Rev. Immunol. 19:2001;375-396.
73. Davis D.M. Assembly of the immunological synapse for T cells and NK cells. Trends Immunol. 23:2002;356-363.
74. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse: a molecular machine controlling T cell activation. Science. 285:1999;221-227.
75. Monks C.R., Freiberg B.A., Kupfer H., Sciaky N., Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:1998;82-86.
76. Shaw A.S., Dustin M.L. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity. 6:1997;361-369.
77. Dustin M.L., Cooper J.A. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat. Immunol. 1:2000;23-29.
78. Alonso M.A., Millan J. The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J. Cell Sci. 114:2001;3957-3965.
79. Harder T., Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr. Opin. Cell Biol. 9:1997;534-542.
80. Simons K., Ikonen E. Functional rafts in cell membranes. Nature. 387:1997;569-572.
81. Zhang W., Trible R.P., Samelson L.E. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity. 9:1998;239-246.
82. Xavier R., Brennan T., Li Q., McCormack C., Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity. 8:1998;723-732.
83. + T cells. J. Immunol. 166:2001;7009-7013.
84. Khan A.A., Bose C., Yam L.S., Soloski M.J., Rupp F. Physiological regulation of the immunological synapse by agrin. Science. 292:2001;1681-1686.
85. Valensin S., Paccani S.R., Ulivieri C., Mercati D., Pacini S., Patrussi L., Hirst T., Lupetti P., Baldari C.T. F-actin dynamics control segregation of the TCR signaling cascade to clustered lipid rafts. Eur. J. Immunol. 32:2002;435-446.
86. Wulfing C., Davis M.M. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science. 282:1998;2266-2269.
87. Viola A., Schroeder S., Sakakibara Y., Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 283:1999;680-682.
88. Dupre L., Aiuti A., Trifari S., Martino S., Saracco P., Bordignon C., Roncarolo M.G. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity. 17:2002;157-166.
89. Lou Z., Jevremovic D., Billadeau D.D., Leibson P.J. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J. Exp. M. 191:2000;347-354.
90. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541-547.
91. Chambers C.A., Kang J., Wu Y., Held W., Raulet D.H., Allison J.P. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor. Blood. 99:2002;4509-4516.
92. Martin M., Schneider H., Azouz A., Rudd C.E. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J. Exp. M. 194:2001;1675-1681.
93. Boullier S., Poquet Y., Halary F., Bonneville M., Fournie J.J., Gougeon M.L. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94-peripheral Vγ9Vδ2 T cells but not on CD94-thymic or mature γδ T cell clones. Eur. J. Immunol. 28:1998;3399-3410.
94. Egen J.G., Allison J.P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity. 16:2002;23-35.
95. Burshtyn D.N., Lam A.S., Weston M., Gupta N., Warmerdam P.A., Long E.O. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors. J. Immunol. 162:1999;897-902.
96. Davis S.J., van der Merwe P.A. The immunological synapse: required for T cell receptor signalling or directing T cell effector function? Curr. Biol. 11:2001;R289-291.
97. + tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J. Immunol. 167:2001;5042-5051.
98. Fleming T.J., Donnadieu E., Song C.H., Laethem F.V., Galli S.J., Kinet J.P. Negative regulation of FcεRI-mediated degranulation by CD81. J. Exp. M. 186:1997;1307-1314.
99. Lee K.H., Holdorf A.D., Dustin M.L., Chan A.C., Allen P.M., Shaw A.S. T cell receptor signaling precedes immunological synapse formation. Science. 295:2002;1539-1542.
100. Stinchcombe J.C., Bossi G., Booth S., Griffiths G.M. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity. 15:2001;751-761.